Dexamethasone (DEX) is known to induce diabetes and dyslipidemia. We have compared fasting triacylglycerol and cholesterol concentrations across 20 lipoprotein fractions and glucose tolerance in control (standard diet) and DEX-treated 7-month-old males of two rat strains, Brown Norway (BN) and congenic BN.SHR-(Il6-Cd36)/Cub (BN.SHR4). These two inbred strains differ in a defined segment of chromosome 4, originally transferred from the spontaneously hypertensive rat (SHR) including the mutant Cd36 gene, a known target of DEX. Compared to BN, the standard-diet-fed BN.SHR4 showed higher cholesterol and triacylglycerol concentrations across many lipoprotein fractions, particularly in small VLDL and LDL particles. Total cholesterol was decreased by DEX by more than 21% in BN.SHR4 contrasting with the tendency to increase in BN (strain*DEX interaction p = 0.0017). Similar pattern was observed for triacylglycerol concentrations in LDL. The LDL particle size was significantly reduced by DEX in both strains. Also, while control BN and BN.SHR4 displayed comparable glycaemic profiles during oral glucose tolerance test, we observed a markedly blunted DEX induction of glucose intolerance in BN.SHR4 compared to BN. In summary, we report a pharmacogenetic interaction between limited genomic segment with mutated Cd36 gene and dexamethasone-induced glucose intolerance and triacylglycerol and cholesterol redistribution into lipoprotein fractions.

Institute of Biology and Medical Genetics Charles University General Teaching Hospital Prague Czech Republic

See more in PubMed

Brotman DJ, Girod JP, Garcia MJ, Patel JV, Gupta M, Posch A, Saunders S, Lip GY, Worley S, Reddy S. Effects of short-term glucocorticoids on cardiovascular biomarkers. The Journal of clinical endocrinology and metabolism. 2005;90:3202–3208. doi: 10.1210/jc.2004-2379. PubMed DOI

Qi D, Rodrigues B. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab. 2007;292:E654–667. doi: 10.1152/ajpendo.00453.2006. PubMed DOI

Gustafsson JA, Carlstedt-Duke J, Poellinger L, Okret S, Wikstrom AC, Bronnegard M, Gillner M, Dong Y, Fuxe K, Cintra A. Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev. 1987;8:185–234. doi: 10.1210/edrv-8-2-185. PubMed DOI

Paterson JM, Seckl JR, Mullins JJ. Genetic manipulation of 11{beta}-hydroxysteroid dehydrogenases in mice. Am J Physiol Regul Integr Comp Physiol. 2005;289:R642–652. PubMed

Sandberg AA, Slaunwhite WR Jr, Carter AC. Transcortin: a corticosteroid-binding protein of plasma. III. The effects of various steroids. J Clin Invest. 1960;39:1914–1926. doi: 10.1172/JCI104216. PubMed DOI PMC

Bernal-Mizrachi C, Weng S, Feng C, Finck BN, Knutsen RH, Leone TC, Coleman T, Mecham RP, Kelly DP, Semenkovich CF. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nature medicine. 2003;9:1069–1075. doi: 10.1038/nm898. PubMed DOI

Seda O, Liska F, Krenova D, Kazdova L, Sedova L, Zima T, Peng J, Pelinkova K, Tremblay J, Hamet P, Kren V. Dynamic genetic architecture of metabolic syndrome attributes in the rat. Physiol Genomics. 2005;21:243–252. doi: 10.1152/physiolgenomics.00230.2004. PubMed DOI

Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem. 1993;268:17665–17668. PubMed

Yesner LM, Huh HY, Pearce SF, Silverstein RL. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol. 1996;16:1019–1025. PubMed

Dwinell MR, Worthey EA, Shimoyama M, Bakir-Gungor B, DePons J, Laulederkind S, Lowry T, Nigram R, Petri V, Smith J. The Rat Genome Database 2009: variation, ontologies and pathways. Nucleic Acids Res. 2009;37:D744–749. doi: 10.1093/nar/gkn842. PubMed DOI PMC

Seda O, Sedova L, Kazdova L, Krenova D, Kren V. Metabolic characterization of insulin resistance syndrome feature loci in three brown Norway-derived congenic strains. Folia Biol (Praha) 2002;48:81–88. PubMed

Seda O, Sedova L, Oliyarnyk O, Kazdova L, Krenova D, Corbeil G, Hamet P, Tremblay J, Kren V. Pharmacogenomics of metabolic effects of rosiglitazone. Pharmacogenomics. 2008;9:141–155. doi: 10.2217/14622416.9.2.141. PubMed DOI

Usui S, Hara Y, Hosaki S, Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res. 2002;43:805–814. PubMed

Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet. 1999;21:76–83. doi: 10.1038/5013. PubMed DOI

Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem. 1999;274:19055–19062. doi: 10.1074/jbc.274.27.19055. PubMed DOI

Ma X, Bacci S, Mlynarski W, Gottardo L, Soccio T, Menzaghi C, Iori E, Lager RA, Shroff AR, Gervino EV. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet. 2004;13:2197–2205. doi: 10.1093/hmg/ddh233. PubMed DOI

Love-Gregory L, Sherva R, Sun L, Wasson J, Schappe T, Doria A, Rao DC, Hunt SC, Klein S, Neuman RJ. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet. 2008;17:1695–1704. doi: 10.1093/hmg/ddn060. PubMed DOI PMC

Qi N, Kazdova L, Zidek V, Landa V, Kren V, Pershadsingh HA, Lezin ES, Abumrad NA, Pravenec M, Kurtz TW. Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone. J Biol Chem. 2002;277:48501–48507. doi: 10.1074/jbc.M206655200. PubMed DOI

Seda O, Kazdova L, Krenova D, Kren V. Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain. Physiol Genomics. 2003;12:73–78. PubMed

Qi D, Pulinilkunnil T, An D, Ghosh S, Abrahani A, Pospisilik JA, Brownsey R, Wambolt R, Allard M, Rodrigues B. Single-Dose Dexamethasone Induces Whole-Body Insulin Resistance and Alters Both Cardiac Fatty Acid and Carbohydrate Metabolism. Diabetes. 2004;53:1790–1797. doi: 10.2337/diabetes.53.7.1790. PubMed DOI

Gounarides JS, Korach-Andre M, Killary K, Argentieri G, Turner O, Laurent D. Effect of Dexamethasone on Glucose Tolerance and Fat Metabolism in a Diet-Induced Obesity Mouse Model. Endocrinology. 2008;149:758–766. doi: 10.1210/en.2007-1214. PubMed DOI

Seda O, Liska F, Sedova L, Kazdova L, Krenova D, Kren V. A 14-gene region of rat chromosome 8 in SHR-derived polydactylous congenic substrain affects muscle-specific insulin resistance, dyslipidaemia and visceral adiposity. Folia Biol (Praha) 2005;51:53–61. PubMed

Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Miller JC, Choi VM, Jenkins SS, Wood A, Cui X, Meng X. Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases. Science. 2009;325:433. doi: 10.1126/science.1172447. PubMed DOI PMC

Yildirim MA, Goh KI, Cusick ME, Barabasi AL, Vidal M. Drug-target network. Nat Biotechnol. 2007;25:1119–1126. doi: 10.1038/nbt1338. PubMed DOI

Single-Gene Congenic Strain Reveals the Effect of Zbtb16 on Dexamethasone-Induced Insulin Resistance

Heterozygous connexin 50 mutation affects metabolic syndrome attributes in spontaneously hypertensive rat

Genomic determinants of triglyceride and cholesterol distribution into lipoprotein fractions in the rat

CD36-deficient congenic strains show improved glucose tolerance and distinct shifts in metabolic and transcriptomic profiles